Home / Blog / Wegovy vs Ozempic vs Zepbound: Which Weight Loss Medication Fits You?

Wegovy vs Ozempic vs Zepbound: Which Weight Loss Medication Fits You?

Published: February 10, 2025Updated: February 12, 2026Author: Top8forWeightloss Editorial TeamCategory: Guides
WegovyOzempicZepboundweight losssemaglutidetirzepatideGLP-1comparison

Wegovy vs Ozempic vs Zepbound: Which Weight Loss Medication Fits You?

Wegovy, Ozempic, and Zepbound all help with weight loss, but they're not interchangeable. When you're choosing, focus on insurance coverage, real-world costs, and which one your doctor thinks will work best for your situation.

Wegovy and Ozempic both use semaglutide, but Wegovy is approved specifically for weight loss. Ozempic is approved for type 2 diabetes, though doctors sometimes prescribe it off-label for weight loss. Zepbound uses tirzepatide, a different medication that targets two hormones instead of one.

Let's break down the real differences. We'll cover what you'll pay, what side effects to expect, and who should choose each one.

Quick Comparison: What's the Difference?

All three medications work by mimicking hormones that help control appetite and blood sugar. But they use different active ingredients and have different FDA approvals.

Wegovy®: Semaglutide approved for weight loss. Higher doses than Ozempic. Usually covered by insurance for weight loss if you meet BMI requirements.

Ozempic®: Semaglutide approved for type 2 diabetes. Lower doses than Wegovy. Insurance often covers it for diabetes, but coverage for weight loss varies.

Zepbound®: Tirzepatide approved for weight loss. Works on two hormones (GLP-1 and GIP). Newer medication, so insurance coverage is still evolving.

What is Wegovy?

Wegovy is semaglutide made by Novo Nordisk, specifically approved by the FDA for chronic weight management. It's the same active ingredient as Ozempic, but at higher doses designed for weight loss.

The typical starting dose is 0.25 mg per week, and you gradually increase to a maintenance dose of 2.4 mg per week. You inject it once a week, usually in your stomach, thigh, or upper arm.

In clinical trials, people taking Wegovy lost about 15% of their body weight over 68 weeks, compared to about 2% for people taking a placebo. That's significant, but results vary person to person.

Cost without insurance is usually $1,300-$1,400 per month. With insurance, copays can drop to $25-$50 per month if your plan covers it. Novo Nordisk also offers a savings card that can bring costs down if you have commercial insurance.

What is Ozempic?

Ozempic is also semaglutide from Novo Nordisk, but it's FDA-approved for type 2 diabetes, not weight loss. The doses are lower: you start at 0.25 mg and can go up to 2 mg per week.

Doctors sometimes prescribe Ozempic off-label for weight loss because it's the same medication as Wegovy, just at lower doses. Some people do lose weight on Ozempic, but the weight loss results aren't as strong as Wegovy because the doses are lower.

Insurance coverage is usually better for Ozempic if you have type 2 diabetes, because that's what it's approved for. If you're using it for weight loss only, coverage depends on your plan. Some plans cover it, some don't.

Cost is similar to Wegovy: around $900-$1,000 per month without insurance. With insurance for diabetes, copays are often $25-$50. The savings card can help if you have commercial insurance.

What is Zepbound?

Zepbound is tirzepatide made by Eli Lilly, approved by the FDA for chronic weight management. It's different from Wegovy and Ozempic because it works on two hormones: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide).

You start at 2.5 mg per week and can increase to a maximum of 15 mg per week. Like Wegovy and Ozempic, you inject it once a week.

In clinical trials, people taking Zepbound lost about 16% of their body weight over 72 weeks, compared to about 3% for people taking a placebo. Some studies suggest tirzepatide might lead to slightly more weight loss than semaglutide, but the difference isn't huge.

Cost without insurance is around $1,000-$1,200 per month. Insurance coverage is still developing since it's newer, but many plans are starting to cover it. Eli Lilly offers a savings card that can bring costs down to $25 per month if you have commercial insurance.

Head-to-Head: Effectiveness

All three medications can help with weight loss. The data shows slight differences, but honestly? The gap between them is smaller than most sites make it seem.

Wegovy: In the STEP trials, people lost an average of 15% of body weight over 68 weeks. About 86% lost at least 5%.

Ozempic: Weight loss results vary because it's approved for diabetes, not weight loss. The doses are lower than Wegovy, so most people see more modest results. If you're using it for weight loss without diabetes, you're essentially getting a lower-dose version of Wegovy.

Zepbound: In the SURMOUNT trials, people lost an average of 16% of body weight over 72 weeks. About 89% lost at least 5%.

That 1% difference between Wegovy and Zepbound? It's real in the studies, but it probably won't matter to you. Your results depend on your starting weight, how your body responds, whether you make lifestyle changes. Some people lose more. Some lose less. Don't pick based on which one "wins" in trials.

Cost Comparison: What You'll Actually Pay

Cost is usually the biggest factor people care about.

MedicationWithout InsuranceWith InsuranceWith Savings Card*
Wegovy®
If covered for weight loss
$1,200-$1,400/month$25-$50/month*$25/month or less
Ozempic®
If covered for diabetes
$900-$1,000/month$25-$50/month*$25/month or less
Zepbound®
If covered for weight loss
$1,100-$1,200/month$25-$50/month*$25/month or less

*Savings Cards: Available for commercial insurance only. Not valid with Medicare, Medicaid, or other government insurance. Eligibility and terms vary by manufacturer.

Note: Actual costs vary by insurance plan, location, and pharmacy. Always confirm pricing with your provider and insurance company. Coverage requirements (prior authorization, BMI thresholds) may apply.

Without insurance: All three are expensive. Wegovy and Zepbound cost $1,000-$1,400 per month. Ozempic is slightly cheaper at $900-$1,000, but that's still a lot of money.

That $1,300 per month isn't just expensive. It's more than many people's rent. If insurance doesn't cover it, you're looking at $15,600 per year. That's a car payment. That's a down payment on a house. It's real money, and most people can't afford it.

With insurance: This is where it gets complicated. If your plan covers weight loss medications, Wegovy and Zepbound copays are often $25-$50 per month. Ozempic is usually covered if you have type 2 diabetes, with similar copays. The problem? Most plans still don't cover weight loss medications at all.

Savings cards: All three manufacturers offer savings cards that can bring costs down if you have commercial insurance. These can reduce copays to $25 per month or less, but they don't work with government insurance like Medicare or Medicaid.

If you're on Medicare or Medicaid, savings cards won't help you. You're paying full price or finding another option. That's the reality of how these programs work.

The catch: insurance coverage varies wildly by plan. Some plans cover weight loss medications, some don't. Some require prior authorization, some don't. You need to call your insurance company to find out what your plan actually covers.

Insurance Coverage: What to Expect

Insurance coverage is probably the most confusing part of this whole process. A few things worth knowing:

Wegovy: Many insurance plans cover it for weight loss if you meet BMI requirements (usually BMI of 30 or higher, or 27+ with a weight-related condition). Some plans require prior authorization or step therapy.

Ozempic: Usually covered if you have type 2 diabetes. Coverage for weight loss only is less common, but some plans do cover it.

Zepbound: Coverage is still developing since it's newer. Some plans cover it, some don't. More plans are adding coverage as time goes on.

The honest answer is: you need to call your insurance company and ask. Don't assume your plan covers any of these. Get it in writing if possible.

Looking for a Provider That Helps With Insurance?

These providers specialize in helping you navigate insurance coverage and prior authorizations.

These picks prioritize insurance navigation and transparent pricing.

Side Effects: What to Expect

All three medications have similar side effects because they work in similar ways. The most common ones are nausea, vomiting, diarrhea, constipation, and stomach pain.

The nausea is real. Some people can't eat for the first few days. Others adjust fine. There's no way to know which camp you'll be in until you try it.

These side effects usually happen when you first start the medication or when you increase your dose. Most people find they get better over time as their body adjusts, but some people struggle with them the whole time they're on the medication.

If you have a job where you can't afford to be nauseous, talk to your doctor about starting on a weekend or when you have a few days off. Teachers, nurses, anyone in customer service, you need to plan for this.

More serious side effects are rare but can include pancreatitis, gallbladder problems, and kidney issues. You should talk to your doctor about your medical history before starting any of these medications.

Some people report that Zepbound causes slightly more nausea than Wegovy or Ozempic, but this varies person to person. There's no clear winner when it comes to side effects. It really depends on how your body responds.

Availability and Shortages

All three medications have had supply issues at different times. When demand is high, certain doses can go on backorder.

Wegovy has had the most consistent supply issues, especially at the mid-range doses (1 mg and 1.7 mg). Novo Nordisk has been working to increase production, but shortages still happen.

When Wegovy goes on backorder, you're stuck. You can't just switch to a different dose. Your provider has to adjust your prescription, and that can take weeks. Some people end up starting over from the beginning dose, which means more side effects and more waiting.

Ozempic has also had shortages, particularly at the 0.5 mg and 1 mg doses. These tend to happen when more people are prescribed the medication.

Zepbound is newer, so supply issues are less common, but they can still happen. As more people start using it, shortages may become more frequent.

If you're starting one of these medications, ask your provider about what to do if your dose is on backorder. Some providers can help you adjust your dosing schedule or switch to a different dose temporarily. Others will tell you to wait, which can derail your progress.

Who Should Choose Wegovy?

Wegovy works well if your insurance covers it for weight loss and you want the higher doses of semaglutide. It's specifically approved for weight loss, which matters when you're fighting with insurance companies.

It's a solid choice if you've tried other methods without success and you're ready to commit to lifestyle changes alongside the medication. This isn't a magic pill. You still need to eat differently and move more. But the medication can make those changes easier to stick with.

Skip it if your insurance doesn't cover weight loss medications and $1,300+ per month isn't in your budget. If you've already spent hours on the phone with your insurance company and they keep saying no, you're looking at paying full price. Some providers help with prior authorizations, but that's not guaranteed.

Also think about weekly injections. Some people don't mind them. Others can't handle needles. If that's a dealbreaker for you, these medications probably aren't right.

Who Should Choose Ozempic?

Ozempic makes the most sense if you have type 2 diabetes. You get blood sugar management and weight loss in one medication, and insurance coverage is usually straightforward because it's approved for diabetes.

If your doctor already prescribed it for diabetes, using it for weight loss too is a no-brainer. Your insurance already covers it. You don't have to fight for coverage or deal with prior authorizations. You're getting both benefits without extra paperwork.

It can work if your doctor wants to start you on lower doses of semaglutide, or if Wegovy isn't available and you want to try semaglutide anyway.

Don't choose it if you don't have diabetes and your insurance won't cover it. Without diabetes coverage, you're paying $900-$1,000 per month for lower doses than Wegovy offers. That's not a good deal.

Who Should Choose Zepbound?

Zepbound is worth considering if you want to try the dual-hormone approach and your insurance covers it. The weight loss results in studies are slightly better than Wegovy, but we're talking about 1% difference. Don't make this decision based on that alone.

It's a good option if you've tried semaglutide (Wegovy or Ozempic) and it didn't work well enough for you. Some people respond better to tirzepatide. Your doctor might suggest it if semaglutide caused too many side effects or didn't give you the results you hoped for.

Skip it if your insurance doesn't cover it and you can't afford $1,000+ per month. It's also newer, so we have less long-term data than Wegovy or Ozempic. If you prefer something with more research behind it, stick with semaglutide.

Compare Providers That Offer These Medications

These providers can help you access Wegovy, Ozempic, or Zepbound with insurance navigation and support.

These picks offer brand-name medications with insurance support.

Compounded Alternatives: When Brand Names Don't Fit

If insurance doesn't cover these medications and you can't afford $1,000+ per month, compounded semaglutide or tirzepatide might be an option.

Compounded medications are prepared by licensed compounding pharmacies. They are not FDA-approved finished products. They're usually cheaper, often $200-$600 per month, and can be a more accessible option when brand-name supply is limited or cost is a barrier.

If you're considering compounded medications, you need to work with a provider who uses a reputable, licensed pharmacy and can answer questions about quality, dosing, and safety. Not all compounded options are created equal.

We have a detailed guide on brand vs. compounded medications if you want to learn more about this option.

Providers That Offer Compounded Options

If brand-name medications aren't in your budget, these providers offer compounded semaglutide and tirzepatide at lower costs.

These picks offer compounded options with transparent pricing and licensed pharmacy sourcing.

How to Get Started

If you're ready to explore one of these medications, the process looks like this:

Step 1: Talk to your doctor. They can help you decide which medication might work best for your situation, check your medical history, and discuss potential side effects.

Step 2: Check your insurance coverage. Call your insurance company and ask specifically about coverage for Wegovy, Ozempic, or Zepbound. Get information about copays, prior authorization requirements, and any restrictions.

This step sounds simple, but calling insurance is frustrating. You'll be on hold. They'll transfer you. You'll explain your situation three times. Bring patience and take notes. Write down who you talked to, what they said, and get a reference number if possible.

Step 3: Consider your budget. If insurance doesn't cover it, can you afford $1,000+ per month? If not, ask your doctor about compounded options or other alternatives.

Step 4: Find a provider. You can get these medications through your regular doctor, a telehealth provider, or a weight loss clinic. Compare options to find one that fits your needs and budget.

Step 5: Start with realistic expectations. These medications can help with weight loss, but they work best when combined with lifestyle changes. Results vary, and you'll need to stay on the medication to maintain weight loss.

Frequently Asked Questions

Is Wegovy the same as Ozempic?

They use the same active ingredient (semaglutide) but have different FDA approvals and dosing. Wegovy is approved for weight loss at higher doses. Ozempic is approved for type 2 diabetes at lower doses.

Which medication leads to more weight loss?

Clinical trials show Zepbound might lead to slightly more weight loss (about 16% vs 15% for Wegovy), but the difference is small. Individual results vary based on many factors.

Can I switch from one medication to another?

Yes, but you should do this under your doctor's supervision. Switching medications requires adjusting doses and monitoring how your body responds.

Do I need to take these medications forever?

Research shows that people who stop taking these medications often regain weight. Many people stay on them long-term to maintain weight loss, but this is something to discuss with your doctor.

Are there generic versions available?

No, there are no generic versions of Wegovy, Ozempic, or Zepbound available yet. Patents protect these medications, so generics won't be available for several years.

Can I use a savings card with insurance?

Yes, if you have commercial insurance (not Medicare or Medicaid), you can usually use the manufacturer savings cards to reduce copays. These can bring costs down to $25 per month or less.

Compare All Provider Options

Ready to see which providers offer these medications? Compare your options here.

We maintain partnerships with the providers featured on this page and may earn a commission upon purchase. These relationships may affect which offers are presented and their placement. Advertiser Disclosure.

Sources and Citations

We pulled information from FDA approvals, clinical trials, and manufacturer data to keep this accurate:

  1. U.S. Food and Drug Administration. "Wegovy (semaglutide) injection, for subcutaneous use." Approved June 2021. FDA Label
  2. U.S. Food and Drug Administration. "Zepbound (tirzepatide) injection, for subcutaneous use." Approved November 2023. FDA Label
  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
  4. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
  5. Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224

Last updated: February 12, 2026. Pricing, coverage, and availability change frequently. Always confirm current costs and coverage with your provider and insurance company.